The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
Effects of Treatment for MAC Infection on Cytokine Expression in HIV-Infected Persons.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Listed as NCT00000860, this observational or N/A phase trial focuses on HIV Infections and Mycobacterium Avium-Intracellulare Infection and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 7 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Baltimore, United States
- • Chicago, United States
- • Cincinnati, United States
- • Cleveland, United States
- • Denver, United States
- • Indianapolis, United States
- • Philadelphia, United States
- • San Francisco, United States
- • Seattle, United States
- • Washington D.C., United States